MOLECULAR PARTNERS AG (MLLCF)
Clinical trial NCT06905028 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2025-04-30 → 2025-04-04 3. completion date: 2026-06-01 → 2027-09-30 4. primary completion date: 2026-06-01 → 2026-10-01
Clinical trial NCT06905028 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2025-04-30 → 2025-04-04 3. completion date: 2026-06-01 → 2027-09-30 4. primary completion date: 2026-06-01 → 2026-10-01
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical